Lanean...

Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

INTRODUCTION: The FDA issued a warning following 24 cases of HBV reactivation during DAA therapy for HCV, including individuals with inactive, occult and past HBV infection. Clinical presentations ranged from asymptomatic fluctuations in HBV DNA to fulminant hepatic failure, liver transplantation an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Expert Opin Drug Saf
Egile Nagusiak: Holmes, Jacinta A., Yu, Ming-Lung, Chung, Raymond T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589072/
https://ncbi.nlm.nih.gov/pubmed/28471314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1325869
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!